Herschel S Weinstein
CIK 1349008 · General Counsel & Secretary · last filed 2025-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
909 THIRD AVENUE
NEW YORK, NY 10022
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | General Counsel & Secretary | 0 | $46.99 | $0 | $0 | 11 | 2025-07-02 |
| Forest Laboratories, LLC (FRX) Delisted | SVP General Counsel | 103,509 | $12.00 | $1.24M | -$691.5K | 23 | 2013-10-24 |
Recent Filings · Page 3 of 4
34 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-04-18 | Forest Laboratories, LLC (FRX) Delisted | Sell (S) | −6,000 | -$210.4K | EDGAR |
| 2011-12-12 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −2,889 | -$86.3K | EDGAR |
| 2011-12-09 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −4,001 | -$120.5K | EDGAR |
| 2011-12-08 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −4,981 | -$149.9K | EDGAR |
| 2011-12-07 | Forest Laboratories, LLC (FRX) Delisted | Grant (A) | +16,700 | $0 | EDGAR |
| 2011-03-10 | Forest Laboratories, LLC (FRX) Delisted | Sell (S) | −7,000 | -$225.1K | EDGAR |
| 2010-12-10 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −2,264 | -$72.7K | EDGAR |
| 2010-12-09 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −3,622 | -$116.6K | EDGAR |
| 2010-12-08 | Forest Laboratories, LLC (FRX) Delisted | Mixed | +38,641 | -$43.7K | EDGAR |
| 2009-12-10 | Forest Laboratories, LLC (FRX) Delisted | Tax (F) | −2,343 | -$72.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.